EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Proposed Response Parameters for Twelve‐Month Drug Trial in Juvenile Systemic Sclerosis: Results of the Hamburg International Consensus Meetings

Ivan Foeldvari iD, Kathryn S Torok iD, Jordi Anton iD, Michael Blakley, Tamás Constantin, Megan Curran, Maurizio Cutolo iD, Christopher Denton iD, Kim Fligelstone, Francesca Ingegnoli, Suzanne C Li, Dana Němcová und 14 weitere

Arthritis Care & Research · 2023

DOI: 10.1002/acr.25171 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Arthritis Care & Research, 2023. Verfasst von Ivan Foeldvari und 25 weiteren Autor:innen. Beteiligte Einrichtung: Schön Klinik Hamburg Eilbek, Hamburg, Germany. Hauptthemen laut MEDLINE: Raynaud Disease, Scleroderma, Systemic. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 52 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Juvenile systemic sclerosis (SSc) is an orphan disease, associated with high morbidity and mortality. New treatment strategies are much needed, but clearly defining appropriate outcomes is necessary if successful therapies are to be developed. Our objective here was to propose such outcomes.

Methods

This proposal is the result of 4 face‐to‐face consensus meetings with a 27‐member multidisciplinary team of pediatric rheumatologists, adult rheumatologists, dermatologists, pediatric cardiologists, pulmonologists, gastroenterologists, a statistician, and patients. Throughout the process, we reviewed the existing adult data in this field, the more limited pediatric literature for juvenile SSc outcomes, and data from 2 juvenile SSc patient cohorts to assist in making informed, data‐driven decisions. The use of items for each domain as an outcome measure in an open label 12‐month clinical trial of juvenile SSc was voted and agreed upon using a nominal group technique.

Results

After voting, the domains agreed on were global disease activity, skin, Raynaud's phenomenon, digital ulcers, musculoskeletal, cardiac, pulmonary, renal, and gastrointestinal involvement, and quality of life. Fourteen outcome measures had 100% agreement, 1 item had 91% agreement, and 1 item had 86% agreement. The domains of biomarkers and growth/development were moved to the research agenda.

Conclusion

We reached consensus on multiple domains and items that should be assessed in an open label, 12‐month clinical juvenile SSc trial as well as a research agenda for future development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Raynaud DiseaseScleroderma, SystemicAdultQuality of LifeChildHumansSkin UlcerScleroderma, Localized

Autor:innen und Institutionen

  • Schön Klinik Hamburg Eilbek, Hamburg, Germany.
  • University of Pittsburgh and Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.
  • Hospital Sant Joan de Déu and Universitat de Barcelona, Barcelona, Spain.
  • Indiana University School of Medicine and Riley Hospital for Children at IU Health, Indianapolis.
  • Semmelweis University, Budapest, Hungary.
  • University of Colorado School of Medicine and Children's Hospital Colorado, Aurora.

ORCID-Profile: Ivan Foeldvari, Kathryn S Torok, Jordi Anton, Maurizio Cutolo, Christopher Denton, Jens Klotsche, Dinesh Khanna, Francesco Del Galdo, Ozgur Kasapcopur, Nicolino Ruperto, Daniel E Furst

Zitieren

APA

Foeldvari, I., Torok, K. S., Anton, J., Blakley, M., Constantin, T., Curran, M., Cutolo, M., Denton, C., Fligelstone, K., Ingegnoli, F., Li, S. C., Němcová, D., Orteu, C., Pilkington, C., Smith, V., Stevens, A., Klotsche, J., Khanna, D., Costa-Reis, P., …, & Furst, D. E. (2023). Proposed Response Parameters for Twelve‐Month Drug Trial in Juvenile Systemic Sclerosis: Results of the Hamburg International Consensus Meetings. Arthritis Care & Research. https://doi.org/10.1002/acr.25171

Vancouver

Foeldvari I, Torok KS, Anton J, Blakley M, Constantin T, Curran M, et al. Proposed Response Parameters for Twelve‐Month Drug Trial in Juvenile Systemic Sclerosis: Results of the Hamburg International Consensus Meetings. Arthritis Care & Research. 2023. doi:10.1002/acr.25171

BibTeX
@article{Foeldvari2023,
  author = {Foeldvari, Ivan and Torok, Kathryn S and Anton, Jordi and Blakley, Michael and Constantin, Tamás and Curran, Megan and Cutolo, Maurizio and Denton, Christopher and Fligelstone, Kim and Ingegnoli, Francesca and Li, Suzanne C and Němcová, Dana and Orteu, Catherine and Pilkington, Clarissa and Smith, Vanessa and Stevens, Anne and Klotsche, Jens and Khanna, Dinesh and Costa-Reis, Patrícia and Del Galdo, Francesco and Hinrichs, Bernd and Kasapcopur, Ozgur and Pain, Clare and Ruperto, Nicolino and Zheng, Alison and Furst, Daniel E},
  title = {Proposed Response Parameters for Twelve‐Month Drug Trial in Juvenile Systemic Sclerosis: Results of the Hamburg International Consensus Meetings},
  journal = {Arthritis Care & Research},
  year = {2023},
  doi = {10.1002/acr.25171}
}
Kostenlos starten →